drugset / Trial / NCT00158808

Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths

NCT00158808 ↗

Phase 2 Completed 175 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

To assess the anti-PRP antibody response one month after vaccination in the groups receiving a fourth consecutive dose of two formulations of DTPw-HBV/Hib vaccine

Timeline

Start
2005-01
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject DTPw-HBV/Hib Vaccine — —